BioCentury
ARTICLE | Clinical News

Genoa Pharmaceuticals preclinical data

June 17, 2013 7:00 AM UTC

In an animal model of IPF, small inhaled doses of GP-101 produced high peak, short duration lung pirfenidone concentrations with significantly greater anti-fibrotic efficacy vs. higher oral doses of p...